By leading the team behind the Moderna COVID-19 vaccine, Kizzmekia Corbett has already changed the world—she is also helping change the future of research.
UMBC Rising Stars discuss their roles in the healthcare and defense industries, with an aim to harness technology to protect from disease and cyber warfare.
Robert Deloatch ’11, M9, has followed his research interests to an exciting job at Apple. We asked Robert about what his experience as a Meyerhoff Scholar means in his life today, and what he would say to a future scholar.
Kizzmekia Corbett’s team was the first to demonstrate a vaccine that successfully stopped viral replication in both the lungs and nose.
After three months of studies, the vaccine her team developed is about to enter a phase I clinical trial, a crucial hurdle on the way to FDA approval.
Hundreds of Meyerhoff Scholars Program alumni gathered to celebrate the program’s 30th anniversary, and to thank Robert E. Meyerhoff for his bold vision.
“To whom much is given, much is required.” Meyerhoff scholars internalize this message, which is introduced during Summer Bridge and is almost as ubiquitous as “Focus, Focus, Focus,” and...
From its very first days, Earnestine Baker, Executive Director Emerita, has been an integral part of the Meyerhoff Scholars Program. UMBC Magazine sat down...
With their hearts in the work and their ears to the ground, the people behind some of UMBC’s longest-standing homegrown programs are solving big societal problems. But the work is never done.
Two Meyerhoff Scholars Program alumnae, Kavita Krishnaswamy, M13, '07, mathematics, and Tabassum Majid, M18, M.A. '18, aging studies, '10, interdisciplinary...